会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 73. 发明授权
    • Lipid-based nitric oxide donors
    • 基于脂质的一氧化氮供体
    • US07696247B2
    • 2010-04-13
    • US10885055
    • 2004-07-06
    • Robert A. HerrmannWendy Naimark
    • Robert A. HerrmannWendy Naimark
    • A61K31/20A01N33/26C07C205/00C07C207/00C07C241/00C07C243/00
    • A61L29/16A61K45/06A61L15/44A61L31/16A61L2300/114A61L2300/416C07C243/42C07J41/0055Y10T436/104165
    • Novel nitric-oxide releasing lipid molecules are provided which comprise a lipid molecule selected from (a) phosphoglycerides, (b) lipids having a sphingosine base as a backbone, (c) monoacylglyerols, (d) diacylglycerols, (e) glycosylacylglycerols, and (f) sterol compounds of the formula: where R is a branched aliphatic chain of eight or more carbon atoms, wherein the lipid molecule is provided with a nitric-oxide containing group which comprises (a) a —S—N═O moiety, (b) a —O—N═O moiety, or (c) a a moiety. Also provided are methods of forming such nitric oxide releasing lipid molecules. Various pharmaceutical compositions, topical liquids and drug delivery systems comprising the nitric-oxide releasing lipid molecules are also described. Further provided are methods for therapeutically administering nitric oxide to patients, methods of treating or preventing various conditions, methods for promoting wound healing and methods of reducing the cells present in an atherosclerotic lesion, which methods utilize the nitric-oxide releasing lipid molecules.
    • 提供新的一氧化氮释放脂质分子,其包含选自(a)磷酸甘油酯,(b)具有鞘氨醇碱作为主链的脂质的脂质分子,(c)单酰基甘醇,(d)二酰基甘油,(e)糖基酰基甘油和( f)下式的甾醇化合物:其中R是具有8个或更多个碳原子的支链脂族链,其中所述脂质分子具有含一氧化氮的基团,其包含(a)-S-N = O部分,( b)-O-N = O部分,或(c)aa部分。 还提供了形成这种一氧化氮释放脂质分子的方法。 还描述了包含释放一氧化氮的脂质分子的各种药物组合物,局部液体和药物递送系统。 还提供了向患者治疗性给予一氧化氮的方法,治疗或预防各种病症的方法,促进伤口愈合的方法以及减少存在于动脉粥样硬化病变中的细胞的方法,该方法利用释放一氧化氮的脂质分子。
    • 74. 发明申请
    • LIPID-BASED NITRIC OXIDE DONORS
    • 基于脂质的氧化氮
    • US20100062055A1
    • 2010-03-11
    • US12619782
    • 2009-11-17
    • Robert A. HerrmannWendy Naimark
    • Robert A. HerrmannWendy Naimark
    • A61K31/56A61K31/15A61K31/131A61K31/23A61K9/127C07J9/00
    • A61L29/16A61K45/06A61L15/44A61L31/16A61L2300/114A61L2300/416C07C243/42C07J41/0055Y10T436/104165
    • Novel nitric-oxide releasing lipid molecules are provided which comprise a lipid molecule selected from (a) phosphoglycerides, (b) lipids having a sphingosine base as a backbone, (c) monoacylglyerols, (d) diacylglycerols, (e) glycosylacylglycerols, and (f) sterol compounds of the formula: where R is a branched aliphatic chain of eight or more carbon atoms, wherein the lipid molecule is provided with a nitric-oxide containing group which comprises (a) a —S—N═O moiety, (b) a —O—N═O moiety, or (c) a moiety. Also provided are methods of forming such nitric oxide releasing lipid molecules. Various pharmaceutical compositions, topical liquids and drug delivery systems comprising the nitric-oxide releasing lipid molecules are also described. Further provided are methods for therapeutically administering nitric oxide to patients, methods of treating or preventing various conditions, methods for promoting wound healing and methods of reducing the cells present in an atherosclerotic lesion, which methods utilize the nitric-oxide releasing lipid molecules.
    • 提供新的一氧化氮释放脂质分子,其包含选自(a)磷酸甘油酯,(b)具有鞘氨醇碱作为主链的脂质的脂质分子,(c)单酰基甘醇,(d)二酰基甘油,(e)糖基酰基甘油和( f)下式的甾醇化合物:其中R是具有8个或更多个碳原子的支链脂族链,其中所述脂质分子具有含一氧化氮的基团,其包含(a)-S-N = O部分,( b)-O-N = O部分,或(c)部分。 还提供了形成这种一氧化氮释放脂质分子的方法。 还描述了包含释放一氧化氮的脂质分子的各种药物组合物,局部液体和药物递送系统。 还提供了向患者治疗性给予一氧化氮的方法,治疗或预防各种病症的方法,促进伤口愈合的方法以及减少存在于动脉粥样硬化病变中的细胞的方法,该方法利用释放一氧化氮的脂质分子。